Events

Past Presentations

AAPS eChalk Talk
January 28th, 2021
11:15AM ET

Register
Emergency Use Authorizations of Coronavirus Vaccines – Similarities and Differences between and EUA and Approval and Legal Ramifications of potential Vaccine Injury

Emergency Use Authorizations as we know them now were borne out of the terror attacks on 9/11 and subsequent anthrax mail incidents and came into law in 2004 and have been amended in 2013 and again in 2016.  As of 1/1/2021, two vaccines have been authorized for use in the United States, each under an EUA.  This talk will explore the history of the EUA, the changes made to the EUA, and how it is being utilized today.  The talk will also discuss the differences between EUAs and Approvals as well as the federal government’s absorption of damages from vaccine injuries – who and what is covered and what are the limitations.

CLE Presentation
February 4th, 2021
12:00PM ET

Register
Vaccine Emergency Use Authorization, Approval, and Liability - Exploring the Science and Law Behind Vaccines for SARS-COV-2
This seminar will be divided into two primary portions.  In part I, Professor David Sanders, of Purdue University, will discuss scientific aspects of the vaccines and SARS-COV-2 and explain how the various vaccine technologies are designed to defend against SARS-COV-2 infection.  In Part II, Eyal H. Barash will discuss the regulatory framework behind the Emergency Use Authorization and how it differs from the approval of a pharmaceutical product.  In addition, the talk will also discuss the Countermeasure Injury Compensation Program, the federal framework for covering injuries due to health counter measures taken in public health emergencies and how it relates to COVID vaccines.

AI Driven Drug Repositioning
and Repurposing Program
April 20th, 2021
Time TBD

Registration Info Coming Soon
SAI and Pharmaceutical Solid Form Patent Strategies for Repurposing Pharmaceutical Assets

This presentation will discuss the basics of pharmaceutical solid forms and why they are important in drug development and repurposing programs. The emergence of AI may also have a great impact in the near future on patent strategies, and Eyal will discuss how we can forecast now about how to go about such patent strategies.